Odontogenic Infections or Lessions are of bacterial or inflammatory origin penetrate primarily into the soft and bony oromaxillofacial tissues to produce submucosal infiltrates and abscesses. Often taking a mild course, these infections may also produce life-threatening complications, depending on a patient's immunocompetence and the site of the inflammatory process. Odontogenic tumors prevalence in Poland was 2% and 11% of all mandibular neoplasms. They are more frequent in males and have their peak incidence in the third decade of life. The glandular odontogenic cyst develops more frequently in Poland that is in about 70–80% in the mandible than in the maxilla.
These infections are typically polymicrobial, and anaerobic bacteria are thought to play a central etiologic role. Antibiotics are an important component in the treatment of odontogenic infections. The drugs most frequently recommended are penicillin (PEN), amoxicillin-clavulanic acid (AMC), and clindamycin (CLI)—despite reports of substantial resistance to CLI among oral pathogens. Researches focusing on Evaluation of Amelotin Expression in Benign Odontogenic Tumors, Evaluation of Neoplastic Nature of Keratocystic Odontogenic Tumor Versus Ameloblastoma, Immunohistochemical detection of laminin-1 and Ki-67 in radicular cysts and keratocystic odontogenic tumors.